Welcome!

News Feed Item

Post-Earnings Review and Highlights - Arena Pharma

Editor Note: For more information about this release, please scroll to bottom

LONDON, August 11, 2014 /PRNewswire/ --

Investor-Edge.com has issued complimentary earnings coverage on Arena Pharmaceuticals Inc. (NASDAQ: ARNA) as the company featured in the headlines on, August 1, 2014. Arena Pharmaceuticals Inc. reported a $56.13 million absolute decline and a $0.15 per diluted share decline in net income per share in the second quarter of 2014. Our free coverage report can be accessed at:

http://www.investor-edge.com/register

Earnings Overview  

For the second quarter of 2014, Arena Pharmaceuticals Inc. reported Research & Development (R&D) expenses of $27.03 million, versus $18.83 million in the year ago quarter. The company's general and administrative expenses increased from $8.60 million in the prior year quarter to $9.13 million during Q2 2014. During the quarter, the company gained $33.3 million on sale of available-for-sale securities in TaiGen. Arena Pharmaceuticals Inc.'s net product sales improved from $1.32 million to $3.53 million in the second quarter of 2014. The biotechnology company reported cash, cash equivalents and short-term investments available-for-sale of $219.11 million as on June 30, 2014.The free research on ARNA can be downloaded as in PDF format at:

http://www.Investor-Edge.com/ARNAFreeReport

During the reported quarter, the company's chronic weight management drug "Belviq" recorded sales of $3.5 million (including $0.4 million from the 15-day free trial voucher redemption), while Eisai, which holds marketing and distribution rights for BELVIQ for most territories worldwide sold $9.9 million worth of Belviq drug doing the same period. Further, Eisai increased its total sales representative's workforce by 200 to 600 sales representatives so as to enable them to reach approximately 92,000 doctors in the United States. In the reported quarter, Arena Pharmaceuticals Inc.'s through its wholly owned subsidiary Arena Pharmaceuticals GmbH entered into a marketing and supply agreement with Teva Pharmaceutical Industries Ltd's Israeli subsidiary to market and distribute Belviq in Israel. Sign up and read the free analyst's notes on ARNA at:

http://www.Investor-Edge.com/ARNA-11082014

Jack Lief, Arena's President and Chief Executive Officer stated that the company has witnessed encouraging advancements in the US commercialization of Belviq, with 43% quarter-over-quarter growth in estimated total prescriptions with, estimated total per week prescriptions crosses the 10,000 mark. Mr. Lief said that during the quarter the company has been able to advance in internally discovered pipeline and lorcaserin life-cycle management programs and has been able to enter into marketing and supply agreement for BELVIQ in Israel.

The biotech company reported total revenue of $12.80 million during the second quarter of 2014, compared with $68.93 million in Q2 2013. The San Diego-based company's net income stood at $7.48 million or $0.03 per share during Q2 2014, versus $40.10 million, or $0.18 per diluted share in the Q2 2013. Analyst at Bloomberg expected revenue of $9.96 million and a net loss of $22.90 billion, or $0.11 loss per share for Q2 2014.

Stock Performance  

Arena Pharmaceuticals Inc.'s shares fell 3.67% to close at $4.46 on, August 01, 2014. However, on Friday, August 08, 2014, the company's shares gained 2.09% to end at $4.39. The company's shares oscillated between $4.26 and $4.42 during the trading session. A total of 2.20 million shares were traded, which is well below its three months average volume of 5.29 million shares. Arena Pharmaceuticals Inc.'s shares have advanced 1.39% in the previous three trading sessions, while the stock has declined 13.24% in the last one month, and 24.96% on YTD basis. The stock is trading below its 50-day and 200-day moving averages of $5.41 and $6.00, respectively. Arena Pharmaceuticals Inc.' stock has a Relative Strength Index (RSI) of 34.30. Visit Investor-Edge and access the latest research on ARNA at:

http://www.Investor-Edge.com/ARNAEarningsCoverage

Sneak Peek to Corporate Insider Trading  

In the last one month, Arena Pharmaceuticals Inc. has not reported any share transactions by insiders to the U.S. Securities and Exchange Commission (SEC). Complimentary in-depth research on ARNA is available at:

http://www.Investor-Edge.com/ARNAInsiderTrading

About Investor-Edge.com 

At Investor-Edge, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Investor-Edge comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

===============

EDITOR'S NOTES:

===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


SOURCE Investor-Edge

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
You know you need the cloud, but you’re hesitant to simply dump everything at Amazon since you know that not all workloads are suitable for cloud. You know that you want the kind of ease of use and scalability that you get with public cloud, but your applications are architected in a way that makes the public cloud a non-starter. You’re looking at private cloud solutions based on hyperconverged infrastructure, but you’re concerned with the limits inherent in those technologies.
For organizations that have amassed large sums of software complexity, taking a microservices approach is the first step toward DevOps and continuous improvement / development. Integrating system-level analysis with microservices makes it easier to change and add functionality to applications at any time without the increase of risk. Before you start big transformation projects or a cloud migration, make sure these changes won’t take down your entire organization.
Automation is enabling enterprises to design, deploy, and manage more complex, hybrid cloud environments. Yet the people who manage these environments must be trained in and understanding these environments better than ever before. A new era of analytics and cognitive computing is adding intelligence, but also more complexity, to these cloud environments. How smart is your cloud? How smart should it be? In this power panel at 20th Cloud Expo, moderated by Conference Chair Roger Strukhoff, paneli...
The current age of digital transformation means that IT organizations must adapt their toolset to cover all digital experiences, beyond just the end users’. Today’s businesses can no longer focus solely on the digital interactions they manage with employees or customers; they must now contend with non-traditional factors. Whether it's the power of brand to make or break a company, the need to monitor across all locations 24/7, or the ability to proactively resolve issues, companies must adapt to...
SYS-CON Events announced today that TMC has been named “Media Sponsor” of SYS-CON's 21st International Cloud Expo and Big Data at Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Global buyers rely on TMC’s content-driven marketplaces to make purchase decisions and navigate markets. Learn how we can help you reach your marketing goals.
Managing mission-critical SAP systems and landscapes has never been easy. Add public cloud with its myriad of powerful cloud native services and this may not change any time soon. Public cloud offers exciting new possibilities for enterprise workloads. But to make use of these possibilities and capabilities, IT teams need to re-think everything they have done before. Otherwise, they will just end up using public cloud as a hosting platform for their workloads, aka known as “lift and shift.”
Cloud promises the agility required by today’s digital businesses. As organizations adopt cloud based infrastructures and services, their IT resources become increasingly dynamic and hybrid in nature. Managing these require modern IT operations and tools. In his session at 20th Cloud Expo, Raj Sundaram, Senior Principal Product Manager at CA Technologies, will discuss how to modernize your IT operations in order to proactively manage your hybrid cloud and IT environments. He will be sharing bes...
Cloud applications are seeing a deluge of requests to support the exploding advanced analytics market. “Open analytics” is the emerging strategy to deliver that data through an open data access layer, in the cloud, to be directly consumed by external analytics tools and popular programming languages. An increasing number of data engineers and data scientists use a variety of platforms and advanced analytics languages such as SAS, R, Python and Java, as well as frameworks such as Hadoop and Spark...
SYS-CON Events announced today that TechTarget has been named “Media Sponsor” of SYS-CON's 21st International Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. TechTarget storage websites are the best online information resource for news, tips and expert advice for the storage, backup and disaster recovery markets.
SYS-CON Events announced today that Telecom Reseller has been named “Media Sponsor” of SYS-CON's 21st International Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Telecom Reseller reports on Unified Communications, UCaaS, BPaaS for enterprise and SMBs. They report extensively on both customer premises based solutions such as IP-PBX as well as cloud based and hosted platforms.
SYS-CON Events announced today that Ayehu will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on October 31 - November 2, 2017 at the Santa Clara Convention Center in Santa Clara California. Ayehu provides IT Process Automation & Orchestration solutions for IT and Security professionals to identify and resolve critical incidents and enable rapid containment, eradication, and recovery from cyber security breaches. Ayehu provides customers greater control over IT infras...
SYS-CON Events announced today that Silicon India has been named “Media Sponsor” of SYS-CON's 21st International Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Published in Silicon Valley, Silicon India magazine is the premiere platform for CIOs to discuss their innovative enterprise solutions and allows IT vendors to learn about new solutions that can help grow their business.
Artificial intelligence, machine learning, neural networks. We’re in the midst of a wave of excitement around AI such as hasn’t been seen for a few decades. But those previous periods of inflated expectations led to troughs of disappointment. Will this time be different? Most likely. Applications of AI such as predictive analytics are already decreasing costs and improving reliability of industrial machinery. Furthermore, the funding and research going into AI now comes from a wide range of com...
SYS-CON Events announced today that MobiDev, a client-oriented software development company, will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. MobiDev is a software company that develops and delivers turn-key mobile apps, websites, web services, and complex software systems for startups and enterprises. Since 2009 it has grown from a small group of passionate engineers and business...
SYS-CON Events announced today that Conference Guru has been named “Media Sponsor” of SYS-CON's 21st International Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. A valuable conference experience generates new contacts, sales leads, potential strategic partners and potential investors; helps gather competitive intelligence and even provides inspiration for new products and services. Conference Guru works with conference organi...